Edmund Tsui Laboratory

Our research focuses on these areas:

• Image Analysis: Develop and validate imaging biomarkers using optical coherence tomography (OCT) and other advanced imaging modalities to quantify intraocular inflammation and monitor disease activity in uveitis. This work aims to improve the objectivity of diagnostic assessments, enhance disease monitoring, and guide treatment decisions by leveraging cutting-edge imaging technologies.
• Advanced Diagnostics: Utilize ocular fluid sampling techniques, such as aqueous and vitreous humor analysis, to improve the diagnosis of uveitis. This includes cytokine profiling, pathogen detection, and biomarker discovery to enable precision diagnostics and uncover underlying etiologies of ocular inflammation.
• Clinical Trials: Design and conduct clinical trials to evaluate novel therapies and refine treatment strategies for uveitis and other ocular inflammatory diseases. Our research encompasses immune-modulating therapies, biologics, small molecules, and targeted immunotherapies aimed at reducing inflammation, preventing vision loss, and improving patient outcomes.